Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT with or without Cisplatin in Stage II Nasopharyngeal Carcinoma
NCT02116231Phase 2Unknown
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Apr 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Cancer Hospital of Guangxi Medical University. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02116231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116231.